Panel - Biotech Public showcase stage
Preparing for Global Commercialization: From Clinical Trial to Market Availability
Date: Monday 13 November, 2023
Time: 12:00pm – 12:30pm
Moderator: Sandra Anderson, , SVP, International Commercialization, Cencora
Panel - Biotech Public showcase stage
Getting Ahead: Expectations For The Biotech Public Markets in 2024
Date: Monday 13 November, 2023
Time: 15:30pm – 16:00pm
Moderator: Dr. Marc-Olivier Bévierre - Life Science Practice Leader, Vintura, part of Cencora
Biotech Public showcase stage
Company showcase presentations
Date: Monday 13 November, 2023
Time: 10:30am – 18:00pm
Chair: Richard Ogborne, Partner, Vintura, part of Cencora
Resource Center
European Joint Clinical Assessment (JCA)
As the European Union takes bold strides towards harmonizing and enhancing its healthcare landscape, the imminent implementation of the Joint Clinical Assessment (JCA) stands as a pivotal moment. With less than 2 years remaining until its full integration, we invite you to explore a wealth of insights that delve deep into the intricacies of this transformative initiative.
Catch up on the latest edition of HTA Quarterly
Additional thought-leadership on HTA and global market access
Pharma Europe Q&A
Tommy Bramley, Senior Vice President, Market Access and Global Consulting, Cencora, had the privilege of chairing the Market Access and Real World Evidence track at the Pharma Europe 2023 conference. He shared some of his takeaways on the exciting future for this area and why meetings like this matter.
